Announces election of new Board members
OTTAWA, April 27 /CNW Telbec/ - Allen-Vanguard Corporation
("Allen-Vanguard" or the "Company") (TSX:VRS) is pleased to announce the
results of the Annual General and Special Meeting of the shareholders of the
Company held on April 25th, 2007 in Ottawa and several initial decisions of
the new Board regarding appointments.
At the meeting shareholders approved the following resolutions.
- To appoint KPMG LLP as auditors of the Corporation and to authorize the
directors of the Corporation to fix the auditors' remuneration;
- To elect Peter M Kozicz, Cary McWhinnie, David O'Blenis, Philip O'Dell
and David Luxton as the members of the board of directors for the
The Company is pleased to welcome Mr. McWhinnie and Mr. O'Blenis as its
newest directors. Mr. McWhinnie is a director of Energenius Inc. and of
Associated Proteins Inc. and a General Partner of Southside Plaza LP.
Mr. O'Blenis is the Chairman of the National Council of the University of New
Brunswick's new Milton F. Gregg, V.C., Centre for the Study of War and Society
and is a retired Canadian Air Force General and retired Chairman of Raytheon
At a board meeting following the Annual and Special Meeting of
shareholders, Mr. O'Blenis was appointed Chairman of the Board and Chair of
the Governance and Compensation Committee and Mr. Kozicz was re-appointed
Chair of the Audit Committee.
"Our new Board is a strong and committed group with a balance of
business, financial and defence industry experience." said David Luxton,
President and Chief Executive Officer. "We are very pleased to have
David O'Blenis and Cary McWhinnie join the Board and would like to extend
sincere thanks to our outgoing directors, David Scott and Roy Peers-Smith for
their valuable service to the Board during these encouraging times."
Allen-Vanguard Corporation and its subsidiaries worldwide operate under
the brand "Allen-Vanguard". The Company develops and markets technologies,
tools and training for defeating and minimizing the effects of hazardous
devices and materials, whether Chemical, Biological, Radiological, Nuclear or
Explosive (CBRNE). The Company's equipment is in service with leading security
and military forces in more than 120 countries. Products include Electronic
Counter-Measures ("ECM") equipment for jamming remote detonation of terrorist
devices, specialty security equipment for Explosive Ordnance Disposal ("EOD"),
remote intervention robots for hazardous applications, vehicle barrier
systems, and personal protective wear for use in dealing with bio-chemical
agents. Allen-Vanguard is the sole, worldwide licensee and/or developer of
patented technologies such as the Universal Containment System and CASCAD Foam
for blast mitigation and decontamination of bio-chemical warfare agents. Head
office operations are located in Ottawa, Ontario, Canada, with manufacturing
operations in Stoney Creek, Ontario; Tewkesbury, U.K.; and Cork, Ireland, and
sales offices in Canada, the U.S., the U.K. and Asia. The Company's shares are
listed on The Toronto Stock Exchange (TSX: VRS). The web site is
This press release may contain forward-looking statements relating to,
among other things, the Company's expectations concerning future product
demand and growth opportunities and customer acceptance of Company's products.
These forward-looking statements are neither promises nor guarantees, but
involve risks and uncertainties that may cause actual results to differ
materially from those in the forward-looking statements. The Company disclaims
any obligation to publicly update or revise any such statements. The Toronto
Stock Exchange has neither approved nor disapproved the contents of this press
To find out more about Allen-Vanguard Corporation (TSX: VRS), visit our
website at www.allen-vanguard.com.
For further information:
For further information: David Luxton, (613) 769-5353